IGC Pharma (IGC) Minority Interest (2011 - 2017)

IGC Pharma (IGC) has reported Minority Interest for 7 consecutive years, with -$9007.0 the latest figure, recorded in Q4 2017.

• On a quarterly basis, Minority Interest changed 0.08% year-over-year to -$9007.0 in Q4 2017; TTM through Dec 2017 was -$9007.0, a 0.08% change from a year earlier, with the FY2017 full-year figure at -$8836.0, down 101.87% from the prior year.
• Minority Interest was -$9007.0 for Q4 2017 at IGC Pharma, down from -$8854.0 in the prior quarter.
• Over five years, Minority Interest peaked at $576803.0 in Q2 2014 and troughed at -$9007.0 in Q4 2017.
• A 5-year average of $393083.6 and a median of $523033.0 in 2014 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest gained 6.96% in 2014 and sank 102.1% in 2017, its largest moves.
• Over 5 years, Minority Interest stood at $531772.0 in 2013, then climbed by 4.67% to $556612.0 in 2014, then advanced by 2.35% to $569702.0 in 2015, then tumbled by 101.58% to -$9000.0 in 2016, then decreased by 0.08% to -$9007.0 in 2017.
• The last three Minority Interest figures came in at -$9007.0 (Q4 2017), -$8854.0 (Q3 2017), and -$8790.0 (Q2 2017), per Business Quant data.